CLASS II Device recall · Reported 31 Jul 2013 · FDA Enforcement Report

BBL Campylobacter CSM Agar (Charcoal-Based Selective Medium) recalled

Becton Dickinson is recalling BBL Campylobacter CSM Agar (Charcoal-Based Selective Medium), distributed nationwide in the US. The recall was initiated on 6 Jun 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot 3078430 Exp 5/30/13
Quantity recalled293 cartons

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1805-2013
FDA event ID
65614
Recalling firm
Becton Dickinson, Sparks, MD
Classification
Class II
Status
Terminated
Recall initiated
6 Jun 2013
FDA classified
24 Jul 2013
Reported
31 Jul 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter

Timeline

6 Jun 2013Recall initiated by company
24 Jul 2013Classified by FDA+48 days
31 Jul 2013Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Microbiological identification media may exhibit reduced levels of Vancomycin.

Product as listed by the FDA

BBL Campylobacter CSM Agar (Charcoal-Based Selective Medium), Catalog # 299614, packaged in cartons of 20 plates, and labeled in part ***Becton, Dickinson and Company 7 Loveton Circle Sparks, MD 21152 USA 800-638-8663 www.bd.com/ds*** BCYE Selective with PAV is used in qualitative procedures for isolation of Legionella species from clinical specimen and nonclinical (environmental) samples. It is similar to the Edelstein formula, except that the concentration of polymyxin B is reduced by half, and vancomycin is substituted for cefamandole.

Where it was distributed

Worldwide distribution: US (nationwide) and countries of:Belgium, Canada, Columbia, Mexico, Singapore, and Taiwan.

Nationwide

Questions about this recall

Why was it recalled?

Microbiological identification media may exhibit reduced levels of Vancomycin.

Which lots are affected?

Lot 3078430 Exp 5/30/13

Where was it sold?

Worldwide distribution: US (nationwide) and countries of:Belgium, Canada, Columbia, Mexico, Singapore, and Taiwan.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

7 other products · FDA event 65614

This product is part of a recall event; the main page for the event is BD BBL Vancomycin Screen Agar, carton of 10 plates recalled.

More recalls from Becton Dickinson

All 364

Other Other Medical Devices recalls

All 13,778